Home -> Law Blog Directory -> Corporate & Securities Law Blogs -> AntitrustProf Blog
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate & Securities Law
: AntitrustProf BlogThe Commission's Pharmaceutical Sector Inquiry - What's Next?
ADVERTISEMENTS
Posted by D. Daniel Sokol College of Europe-Collège d'Europe Global Competition Law Centre The Commission's Pharmaceutical Sector Inquiry - What's Next? Dominik Schnichels, Head of the Pharmaceutical Task Force, European Commission James Killick, Partner, White & Case 20 May 2010...Full post as published by AntitrustProf Blog on May 06, 2010 (boomark / email).
Lawsuits and Settlements
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

More about the European Pharmaceutical Sector: Procedural Changes
EU Finds Anti-Competitive Abuse Of Pharmaceutical Patents, Launches Antitrust Action
European Commission Releases Preliminary Report on Competition in Pharmaceutical Sector
CLE on Pharmaceutical Antitrust Initiatives and Developments
European Commission Probes Pharmaceutical Sector
European Commission Attacks Practices That Prevent Competition From Generic Drugs








